Delivery Order SPE2DB22D1002-SPE2DB23FLEM5
Award Date 8/2/23
Potential Completion Date 8/3/23
Potential Value $4.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,666.66 delivery order contract to Amerisourcebergen Drug Corporation for the supply of 4562084498, Glatiramer 40 mg/ml syringes. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 8, 2023 under a firm fixed price arrangement. No subcontractors or set aside designations were indicated. The Defense Logistics Agency functions to support military readiness by...
- The Defense Logistics Agency awarded a $1,942.98 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562053140, Glatiramer 40 MG/ML Syringes. The delivery order was issued under an existing prime vendor contract vehicle and calls for the delivery of the specified pharmaceutical product to a facility in Conshohocken, Pennsylvania. Performance will be completed by September 6, 2023. No set aside provisions or subcontractors were identified. The Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Glatiramer 40 mg/ml syringes, valued at $5,083.61. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the agency's pharmaceutical procurement strategy through established contract vehicles....
- The Defense Logistics Agency awarded a $6,973.17 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Glatiramer 40 mg/ml syringes, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Glatiramer 40 mg/ml syringes valued at $5,860.02, with an ultimate completion date of September 11, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems...
- The Defense Logistics Agency awarded a delivery order valued at $2,930.01 to AmerisourceBergen Drug Corp for Glatiramer 40 mg/ml syringes, with an ultimate completion date of June 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,930.01 to AmerisourceBergen Drug Corp for Glatiramer 40 mg/mL syringes. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract under a larger indefinite...
- The Defense Logistics Agency Troop Support Medical awarded a $15,409.35 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40 mg/ml syringes of glatiramer, to be delivered from its Conshohocken, Pennsylvania facility by August 29, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were identified. This order is likely associated with the DLA's stocking and distribution of...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $2,832.12 to supply 40 mg/ml Glatiramer syringes. The delivery order was awarded on December 18, 2023 against an indefinite delivery contract held by Amerisourcebergen Drug Corp with the Defense Logistics Agency Troop Support Medical to provide pharmaceuticals and medical supplies. Performance will take place at Amerisourcebergen's facility in Conshohocken,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of glatiramer 40 mg/ml syringes, a specialty pharmaceutical product, with a potential value of $2,832.12. It is a firm fixed price delivery order contract with a completion date of February 6, 2024. Amerisourcebergen Drug Corp is...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB23FLEM5Delivery Order
The Defense Logistics Agency awarded a $4,879.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40mg/mL glatiramer syringes. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to its Conshohocken, Pennsylvania facility by August 3, 2023 to support DLA's medical supply needs. No subcontractors or set aside designations were indicated. DLA manages the global supply chain for the Department of Defense, ensuring troops have the medical supplies and equipment necessary to carry out their missions. This small order for glatiramer, a drug used to treat multiple sclerosis, is consistent with DLA's role of procuring pharmaceuticals and other critical health commodities.
Generated 12/17/23, 11:51 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 8/2/23 |